Wesley Hsu to Cell Line, Tumor
This is a "connection" page, showing publications Wesley Hsu has written about Cell Line, Tumor.
Connection Strength
0.668
-
Hsu W, Mohyeldin A, Shah SR, ap Rhys CM, Johnson LF, Sedora-Roman NI, Kosztowski TA, Awad OA, McCarthy EF, Loeb DM, Wolinsky JP, Gokaslan ZL, Quiñones-Hinojosa A. Generation of chordoma cell line JHC7 and the identification of Brachyury as a novel molecular target. J Neurosurg. 2011 Oct; 115(4):760-9.
Score: 0.326
-
Hu Y, Feng X, Mintz A, Petty WJ, Hsu W. Regulation of brachyury by fibroblast growth factor receptor 1 in lung cancer. Oncotarget. 2016 Dec 27; 7(52):87124-87135.
Score: 0.119
-
Hu Y, Singh R, Deng Z, Mintz A, Hsu W. Liposome-Protamine-DNA Nanoparticle-Mediated Delivery of Short Hairpin RNA Targeting Brachyury Inhibits Chordoma Cell Growth. J Biomed Nanotechnol. 2016 Oct; 12(10):1952-61.
Score: 0.117
-
Hsu W, Siu IM, Pradilla G, Gokaslan ZL, Jallo GI, Gallia GL. Animal model of intramedullary spinal cord glioma using human glioblastoma multiforme neurospheres. J Neurosurg Spine. 2012 Mar; 16(3):315-9.
Score: 0.084
-
Brastianos PK, Brastianos HC, Hsu W, Sciubba DM, Kosztowski T, Tyler BM, Recinos VR, Burger P, Grossman SA. The toxicity of intrathecal bevacizumab in a rabbit model of leptomeningeal carcinomatosis. J Neurooncol. 2012 Jan; 106(1):81-8.
Score: 0.021